Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Promotion of “Low T” and the Role of Testosterone Clinical Trials

Promotion of “Low T” and the Role of Testosterone Clinical Trials Letters To actually revolutionize health care with e-health inter- media viewer (.wmv) files when viewed on a personal com- ventions, we can learn from the pharmaceutical industry, puter (PC) with Microsoft Windows and Internet Explorer. Re- where viable products emerge after numerous cycles of trial cent statistics show that Windows is the operating system on and error. Perhaps instead of focusing on evaluations in real- more than 78% of all PCs sold, while Apple’s Macs represent life pragmatic situations, we should begin with rigorously approximately 4% of the market. During the course of the studying the potential benefits in groups with easier chances study (2010-2011), PCs outsold Macs by a ratio of 20:1. We of success, such as patients with good computer literacy. While therefore doubt that technical difficulties adequately ac- this search for efficacy will initially limit generalizability, it will count for failure of 95% of our patients to view the video. help to determine to what degree the interventions are us- Makai and colleagues draw an interesting parallel be- able and guide redesign of the interventions. If there is no ef- tween the design of e-health interventions and drug develop- fect on such a group, serious redesign http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Promotion of “Low T” and the Role of Testosterone Clinical Trials

Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/promotion-of-low-t-and-the-role-of-testosterone-clinical-trials-0R6VezY0ns
Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2013.12750
pmid
24493613
Publisher site
See Article on Publisher Site

Abstract

Letters To actually revolutionize health care with e-health inter- media viewer (.wmv) files when viewed on a personal com- ventions, we can learn from the pharmaceutical industry, puter (PC) with Microsoft Windows and Internet Explorer. Re- where viable products emerge after numerous cycles of trial cent statistics show that Windows is the operating system on and error. Perhaps instead of focusing on evaluations in real- more than 78% of all PCs sold, while Apple’s Macs represent life pragmatic situations, we should begin with rigorously approximately 4% of the market. During the course of the studying the potential benefits in groups with easier chances study (2010-2011), PCs outsold Macs by a ratio of 20:1. We of success, such as patients with good computer literacy. While therefore doubt that technical difficulties adequately ac- this search for efficacy will initially limit generalizability, it will count for failure of 95% of our patients to view the video. help to determine to what degree the interventions are us- Makai and colleagues draw an interesting parallel be- able and guide redesign of the interventions. If there is no ef- tween the design of e-health interventions and drug develop- fect on such a group, serious redesign

Journal

JAMA Internal Medicine – American Medical Association

Published: Feb 1, 2014

References

  • Promoting “low T”: a medical writer’s perspective.
    Braun, SR
  • Low “T” as in “template”: how to sell disease.
    Schwartz, LM; Woloshin, S
  • Testosterone treatment of men with alcoholic cirrhosis: a double-blind study.
  • Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle.
    Bhasin, S; Woodhouse, L; Casaburi, R
  • Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.
    Xu, L; Freeman, G; Cowling, BJ; Schooling, CM